IPO4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.101200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.204800E-01
Normal-vs-Stage2
4.261000E-01
Normal-vs-Stage3
7.141000E-01
Normal-vs-Stage4
2.881800E-01
Stage1-vs-Stage2
7.623000E-01
Stage1-vs-Stage3
3.124600E-01
Stage1-vs-Stage4
9.487200E-01
Stage2-vs-Stage3
1.653570E-01
Stage2-vs-Stage4
8.743600E-01
Stage3-vs-Stage4
2.701000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.903600E-01
Normal-vs-AfricanAmerican
1.138830E-01
Normal-vs-Asian
7.001600E-01
Caucasian-vs-AfricanAmerican
3.074600E-01
Caucasian-vs-Asian
2.364000E-01
AfricanAmerican-vs-Asian
4.233400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.827800E-01
Normal-vs-Female
4.296800E-01
Male-vs-Female
8.895600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.506100E-02
Normal-vs-Age(41-60Yrs)
2.603200E-01
Normal-vs-Age(61-80Yrs)
5.346800E-01
Normal-vs-Age(81-100Yrs)
1.731770E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.398600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.921800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.935600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.853600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.421810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.386500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.690600E-01
Normal-vs-Daily Drinker
4.036600E-01
Normal-vs-Weekly Drinker
2.524200E-01
Normal-vs-Occasional Drinker
8.640000E-02
Normal-vs-Social Drinker
3.380400E-01
Non Drinker-vs-Daily Drinker
7.166400E-01
Non Drinker-vs-Weekly Drinker
7.244000E-01
Non Drinker-vs-Occasional Drinker
3.610200E-01
Non Drinker-vs-Social Drinker
5.389000E-01
Daily Drinker-vs-Weekly Drinker
9.339800E-01
Daily Drinker-vs-Occasional Drinker
6.333400E-01
Daily Drinker-vs-Social Drinker
7.542000E-01
Weekly Drinker-vs-Occasional Drinker
8.628600E-01
Weekly Drinker-vs-Social Drinker
8.969400E-01
Occasional Drinker-vs-Social Drinker
9.618000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.635600E-01
Normal-vs-Grade 2
7.999000E-01
Normal-vs-Grade 3
9.446800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.853200E-01
Grade 1-vs-Grade 3
2.298800E-01
Grade 1-vs-Grade 4
8.635600E-01
Grade 2-vs-Grade 3
9.809900E-04
Grade 2-vs-Grade 4
7.999000E-01
Grade 3-vs-Grade 4
9.446800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.309200E-01
Normal-vs-NonDiabetic
3.795800E-01
Diabetic-vs-NonDiabetic
3.896200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.679800E-01
Normal-vs-NoPancreatitis
4.033600E-01
Pancreatitis-vs-NoPancreatitis
3.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.315200E-01
Normal-vs-N1
4.525000E-01
N0-vs-N1
8.648600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.358500E-04
Normal-vs-TP53-NonMutant
1.283870E-02
TP53-Mutant-vs-TP53-NonMutant
1.252830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
